2m 2m 2m 2m 2m 2m 2m
JASPER THERAPEU (JSPR)
NASDAQ
$0.68-$0.04 (-5.59%)
Price as of Aug 21, 2026 6:18 PM EDT- $23.8MMarket Cap
- -75.56%1-Year Change
- BiotechnologyIndustry
JASPER THERAPEU (JSPR)
$0.68-$0.04 (-5.59%)
JSPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.72 | ||
Change | +$0.02 (+3.59%) | ||
Open | $0.68 | ||
High | $0.74 | ||
Low | $0.68 | ||
Previous Close | $0.69 | ||
Volume | 780,749 | ||
30-Day Average Volume | 774,270 | ||
1-Week Change | -9.38% | ||
1-Month Change | -7.01% | ||
1-Year Change | -75.56% | ||
3-Year Change | -94.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.3M | ||
Total Assets | $11.8M | ||
Market Cap | $23.8M | ||
Enterprise Value | $16.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$6.9M | ||
EBIT | $0.00 | ||
EBITDA | $21,000.00 | ||
Net Working Capital | $3.7M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | 805 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 17 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/04/2024 | ||
Earnings & Revenue